Along similar lines, another post hoc analysis of five RCTs of belimumab showed that negative anti-dsDNA or normal/high C3/C4 levels were associated with enhanced protection against severe SLE flares or renal flares [114]. Here, C4A is linked to systemic lupus erythematosus.